Skip to Content
Home > Services > Cancer Care > Successful Outcomes > Clinical Trials > Clinical Trials Details
<< Back to Results
Astex AT13397-05 is a Study of HSP90 Inhibitor AT13387 Alone and in Combination with Crizotinib in the Treatment of Non-small Cell Lung Cancer (NSCLC)
Learn more information on clinical trial - Astex AT13397-05.
Send Us Your Questions, Comments or Feedback.
Awards & Certifications
Follow Us Online
©2014 Cone Health ~ Greensboro, NC